ArticleJournal for immunotherapy of cancer2022
Correction: Overcoming resistance to αPD-1 of MMR-deficient tumors with high tumor-induced neutrophils levels by combination of αCTLA-4 and αPD-1 blockers.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.